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Malaria, though preventable and treatable, remains a major 
cause of morbidity and mortality in the developing world. Its 
greatest toll is exacted on populations in sub-Saharan Africa, 
resulting in significant morbidity and mortality and impeding 
economic development in the region. The World Health 
Organization (WHO) estimated that there were 801 000 malaria 
deaths in 2006 in Africa, 85% of whom were children <5 years 
of age.1 The increase in case-fatality rates in recent years is 
attributed largely to increasing resistance to antimalarial drugs 
in Plasmodium spp.
As a result of effective malaria control for over 50 years in 
South Africa, the risk of malaria transmission is low, seasonal, 
and limited to the low-lying north-eastern areas of the country 
(KwaZulu-Natal, Mpumalanga and Limpopo provinces); 
therefore, the South African population living in both malaria-
risk and malaria-free areas are non-immune. The burden 
of disease in malaria-risk areas has been reduced through 
regional strengthening of vector control and use of artemisinin-
based combination therapy. Patients and health care workers, 
particularly in malaria-free areas, may be less likely to suspect 
or recognise malaria because of the pronounced decline in 
malaria cases nationally. While artemisinin combination 
therapy (ACT) for uncomplicated malaria and quinine for 
severe or complicated malaria form part of the national policy 
in malaria-risk areas in South Africa, ACTs are not available in 
the public sector outside these areas, and common practice is to 
administer a 7-day course of quinine treatment.
South African residents and visitors are travelling more 
frequently within the African sub-region. Gauteng, a malaria-
free province and home to approximately 9.7 million people, 
is the major hub for domestic and international travel. In 2005, 
an estimated 1 256 000 nationals of mainland African countries 
entered South Africa, many from the 45 countries endemic 
for malaria within the WHO Afro region.1 Data on the travel 
destinations of South Africans visiting neighbouring countries 
are sparse, especially at ports of entry where visas are not 
required.
Imported malaria is well documented in developed 
countries, particularly in Europe and the Americas.2 However, 
few scientific research reports address the burden of malaria 
imported into non-endemic parts of African countries. This 
critical information may help to inform the need for health 
worker training, community health promotion and a change in 
drug policy.
Methods
Objective
To describe the burden of malaria in Gauteng Province, and to 
identify potential risk factors for severe disease, we conducted 
a survey from December 2005 to end November 2006.
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Objectives. To describe the burden of malaria in Gauteng 
Province, and to identify potential risk factors for severe 
disease.
Design. We conducted a prospective survey of malaria cases 
diagnosed in hospitals throughout Gauteng from December 
2005 to end November 2006.
Outcome measures. Malaria frequency, severity, and treatment.
Results. We identified 1 701 malaria cases; 1 548 (91%) were 
seen at public sector hospitals and 153 (9%) at private 
hospitals; 1 149 (68%) patients were male. Median age was 27 
years (range 1 month - 89 years). Most (84%) infections were 
presumed to be acquired in Mozambique. Disease severity 
did not differ by age or sex. Patients who were South African-
born were more likely to have severe disease (OR=1.43 (1.08 
- 1.91)), as were patients who experienced a delay >48 hours 
between onset of symptoms and diagnosis or treatment 
(OR=1.98 (1.48 - 2.65)). While most patients appropriately 
received quinine, only 9% of severe malaria cases received the 
recommended loading dose.
Conclusions. The incidence of malaria in Gauteng was higher 
than previously reported, emphasising the need to prevent 
malaria in travellers by correct use of non-drug measures 
and, when indicated, malaria chemoprophylaxis. Disease 
severity was increased by delays between onset and treatment 
and lack of partial immunity. Providers should consult the 
latest guidelines for treatment of malaria in South Africa, 
particularly about treatment of severe malaria. A change in 
drug policy to artemisinin combination therapy for imported 
uncomplicated malaria in non-malaria risk provinces should 
be strongly considered.
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Case definition
A case of malaria was defined as illness in any patient seen 
in a hospital in Gauteng Province and diagnosed and treated 
as malaria on the basis of clinical suspicion with or without 
laboratory confirmation of infection with human Plasmodium 
species (by blood smear or rapid antigen detection methods), 
between 1 December 2005 and 30 November 2006.
Case ascertainment
Every hospital in South Africa is required by law to employ at 
least one Infection Control Officer (ICO) whose responsibilities 
include the prevention and management of reportable and 
nosocomial infectious diseases.3 Since malaria is a nationally 
notifiable disease, clinicians and laboratories should report 
hospital-based cases internally to ICOs, who subsequently 
investigate and report cases to the provincial department of 
health. ICOs and clinicians were recruited to collect data on all 
malaria cases in each of the public and private sector hospitals 
in Gauteng. The provincial department of health encouraged 
public sector participation during departmental meetings, 
and private hospital authorities invited participation by their 
facility personnel through internal circulars and meetings.
Data collection
Participating ICOs and clinicians completed a single-page 
questionnaire for each eligible malaria case. Interviewers 
obtained the date and country of birth, and the presumed 
location of malaria infection, when the patient or relative was 
able to provide that information. Disease severity classification 
was based on the national guidelines for the treatment of 
malaria, where severe or complicated malaria was defined 
as symptomatic malaria with signs of severity or evidence of 
vital organ dysfunction, while uncomplicated malaria was 
symptomatic malaria not meeting the criteria of severity.4
Data analysis
Data were entered into a Microsoft Access database, and 
we conducted the analysis using EpiInfo version 3.3.2. We 
calculated age- and sex-specific incidence rates using data from 
the 2001 national census.5 We described basic epidemiological 
parameters and conducted bivariate analysis on independent 
variables with severity of illness as the dependent variable. 
We tested for differences in normally distributed continuous 
variables between groups using Student’s t-test, and applied 
non-parametric methods to non-normally distributed data. For 
categorical variables, we used chi-squared or Fischer’s exact 
test for proportions, defining the level of significance as 95%. 
We quantified measure of association by odds ratios (OR) and 
calculated 95% confidence intervals around the ORs.
Results
Participants from 47 health care facilities submitted 
questionnaires on 1 701 malaria cases; 1 548 (91%) were seen at 
public sector hospitals and 153 (9%) at private sector hospitals. 
Large public sector tertiary and secondary hospitals, namely 
Chris Hani Baragwanath Hospital (17%), Leratong Hospital 
(14%), Edenvale Hospital (12%) and Natalspruit Hospital (10%) 
reported cases most frequently.
Males accounted for 1 149 (68%) patients; median patient age 
was 27 years (range 1 month to 89 years). Among 1 580 (93%) 
patients for whom data on age and sex were available, there 
was a bimodal age distribution among males and females, 
with peaks in children under 10 years and adults between 
20 and 49 years (Fig.1). While incidence rates were similar 
among children of both sexes, rates among males older than 
15 years were significantly higher than those of their female 
counterparts (p<0.05). Among 282 female patients between the 
ages of 13 and 54 years, 39 (14%) were pregnant, 159 (56%) 
were not pregnant, and pregnancy status was not known 
in 84 (30%). The majority of malaria cases occurred in the 
summer months, with a distinct peak in January (Fig. 2). Data 
on country of birth were available for 1 343 (79%) patients, of 
whom 612 (46%) were born in Mozambique, 607 (45%) in South 
Africa, 113 (8%) in other African countries, and 11 (<1%) on 
other continents.
In 1 593 (94%) cases, the patients or their relatives were 
able to provide information on the presumed geographic 
region where infection was acquired; 1 336 (84%) suspected 
acquisition of infection in Mozambique, 83 (5%) in malaria-risk 
parts of South Africa, 154 (10%) in other African countries, 
and 2 (<1%) in south-east Asia. Eight (<1%) patients had not 
travelled outside Gauteng province; one of these patients was a 
health care worker who sustained a needle-stick injury from a 
patient with confirmed malaria. The remaining 7 patients had 
insufficient data to evaluate the potential for autochthonous 
transmission.
Among the 1 662 (98%) cases in which the diagnostic method 
was reported, 1 635 (98%) were diagnosed on the basis of a 
positive blood smear, 22 (1%) on rapid diagnostic tests, and 
5 (<1%) on clinical features alone. In 1 603 (94%) cases where 
the detected Plasmodium species was identified, P. falciparum Figure 1.  Incidence of alaria per 100,000 population by age group and sex—
Gauteng, December, 2005–November, 2006 
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 Fig. 1.  Incidence of malaria per 100 000 population by age group and sex 
in Gauteng, December 2005 - November 2006.Figure 2.  Malaria cases by month—Gauteng, December, 2005–November, 2006 
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 Fig. 2.  Malaria cases by month in Gauteng, December 2005 - November 
2006.
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accounted for 1 537 (96%) infections, P. malariae for 39 (2%), 
mixed infections for 19 (1%), P. ovale for 5 (<1%), and P. vivax 
for 3 (<1%).
Among 1 430 cases where the interval between onset of 
symptoms and diagnosis or treatment was recorded, 98 (7%) 
cases were diagnosed or treated within 12 hours, 289 (20%) 
between 12 and 24 hours, and 268 (19%) between 24 and 48 
hours, while 775 (54%) indicated delays of more than 2 days. 
In cases where delays exceeded 2 days, the reasons cited were 
that the patient did not suspect malaria (77%), that the initial 
health care provider did not suspect malaria (21%), and that 
the patient did not have immediate access to health care (2%).
Data on disease severity were available for 1 374 (81%) 
cases, of which 1 057 (77%) were classified as uncomplicated 
and 317 (23%) as severe. Disease severity did not differ by age 
or sex (Table I). Patients who were South African-born were 
more likely to have severe disease (OR=1.43 (1.08 - 1.91)), 
as were patients who experienced a delay of greater than 48 
hours between onset of symptoms and diagnosis or treatment 
(OR=1.98 (1.48 - 2.65)).
Treatment data were available for 1 645 (97%) cases. Quinine 
was administered to 1 555 (95%) patients, of whom 817 (53%) 
received quinine alone, 565 (36%) received a combination of 
quinine and doxycycline, 172 (11%) received a combination of 
quinine and clindamycin, and 1 received quinine together with 
chloroquine. Four patients with P. falciparum malaria received 
chloroquine alone. Among severe cases, 27 (9%) received 
loading doses of quinine.
Vital outcome data were reported for 970 (57%) cases. Thirty-
eight (4%) patients died, all of whom had severe malaria, of 
whom males accounted for 25 (66%); their median age was 33 
years (range 1 - 75 years). Among the 9 females between 13 
and 54 years who died, 1 was pregnant, 3 were not pregnant, 
and pregnancy status was not known in 5 patients. Among 28 
deceased with a recorded country of birth, 17 (61%) were born 
in South Africa.
Discussion
This study demonstrates the public health significance 
of imported malaria infections in Gauteng Province. The 
incidence of malaria in Gauteng was higher than previously 
reported to the National Department of Health6 and, while 
the increase may be attributable to a real increase in cases, it 
is probably owing to increased reporting, possibly stimulated 
by the research project, provincial health department 
education efforts, and concurrent media reports. However, 
the cases included in the study were still an underestimate 
of disease incidence in the province. A concurrent analysis of 
laboratory reports estimated that the number of cases that were 
laboratory confirmed in the province during the study period 
was almost three times that counted in the survey (personal 
communication, M Tepper, National Health Laboratory 
Service).7 During this period, 6 513 cases were reported 
from Limpopo Province, 4 794 from Mpumalanga Province, 
and 1 284 from KwaZulu-Natal. These are all provinces in 
which the Malaria Control Programme operates, there is 
greater compliance with malaria case reporting, and accurate 
quantification of malaria is critical to inform malaria control 
activities.
Among the Gauteng study population, rates of disease 
were higher in children and men of economically productive 
age. The increased rates in children were probably because 
of increased severity of infection in this age group, raising 
the likelihood of parents taking them to hospital. In addition, 
providers may tend to admit children more commonly than 
adults, raising their opportunity for inclusion in this study. 
The increased rate in men is consistent with labour-related 
migration between malaria-endemic regions and Gauteng. 
The majority of our patients attended public health care 
facilities, reflecting the appreciable burden of disease among 
population groups unable to afford private health care, which 
dispels the notion of imported malaria being confined to 
affluent recreational travellers. South African guidelines and 
community education messages encompass the basic principles 
of malaria prevention, namely: awareness of risk, prevention 
of bites through application of N,N-diethyl-3-methyl-
benzamide (DEET)-containing mosquito repellants,8,9 and 
chemoprophylaxis when appropriate. The latter intervention 
is expensive and not readily available from public sector 
health facilities. Research on South African travellers in the 
1990s demonstrated a correlation between increasing use of 
chemoprophylaxis and a decrease in numbers of reported 
infections.10 However, no recent studies have confirmed this 
finding. In general, even though travellers’ adherence to 
antimalarial chemoprophylaxis is notoriously low, especially on 
regimens other than the shorter course atovaquone-proguanil 
combination, this option must be weighed against the risk of 
becoming infected and developing severe disease.
The burden of severe malaria in the study population is 
increased by delays in diagnosis or treatment exceeding 48 
hours. In addition, the increased severity of illness associated 
with being born in a non-endemic region emphasises the 
vulnerability of populations lacking partial immunity to 
severe malaria. Hospitalisation for uncomplicated malaria is 
Table I. Characteristics of malaria cases by severity in Gauteng, December 2005 - November 2006
    Uncomplicated malaria   Severe and complicated
               (N=1 057)                 (N=317)
Median age, years (range)             27 (<1 - 89)                 27 (<1 - 75)
Male (%)               721 (68%)                 202 (64%)
Pregnant females (%)             20 (2%)                 15 (5%)
South African born (%)             370 (35%)                 143 (45%)
Delay >48 hours* (%)             444 (42%)                 187 (59%)
* Between onset and diagnosis/treatment.
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unnecessarily prolonged by artemether-lumefantrine not being 
available in the public sector hospitals in Gauteng (and other 
malaria-free provinces in South Africa).
Our study was subject to several limitations. We could 
not fully quantify the incidence of malaria in Gauteng 
because hospitals might not have submitted questionnaires 
on all patients. Patients treated as outpatients would have 
been under-represented in this study, which could explain 
the difference in cases found in the concurrent analysis of 
laboratory reports. However, guidelines recommend initial 
admission of all malaria patients in non-malaria risk areas 
of South Africa. The association between risk factors and 
malaria severity might have been subject to confounding 
or effect modification because we were unable to reliably 
classify patients as non-immune or semi-immune to malaria, 
and we had no record of patients’ general immune status, 
including the effects of human immunodeficiency virus (HIV) 
infection. In a study conducted among 336 patients at Chris 
Hani Baragwanath Hospital, in Gauteng, Cohen et al. found an 
increased prevalence of severe malaria in HIV-positive patients 
with CD4 counts less than 200 x 106 cells/l, although semi-
immunity owing to prior residence in a highly endemic malaria 
area reduced the risk of severe malaria in both HIV-positive 
and HIV-negative patients.11 A similar increase in risk of severe 
malaria, acute renal failure, and malaria-related mortality was 
found in KwaZulu-Natal.12 To keep the questionnaire short 
and based on prior research indicating inaccuracy in reporting 
of adherence,13 we did not collect data on chemoprophylaxis 
use. The high case-fatality rate among patients with known 
outcome of illness might have occurred as a result of reporting 
bias because of increased attention to thorough documentation 
of cases with fatal outcomes, while cases in which patients 
survived were less likely to have a specific outcome reported.
The number of travellers moving between non-endemic 
parts of African countries and malaria-endemic areas is likely 
to increase as a result of displacement of vulnerable population 
groups through wars or impoverishment, the development 
of transport infrastructure, and continued labour-related 
migration. In addition, South Africa will be hosting the 
Fédération Internationale de Football Association (FIFA) World 
Cup soccer tournament this year, which is likely to draw large 
international crowds with many visitors travelling the sub-
region and at risk for malaria infection. These findings indicate 
the need for health care provider and patient education to 
prevent malaria through reliable use of non-drug measures 
and, when indicated, malaria chemoprophylaxis. These 
measures would include awareness of malaria risk areas (Fig. 
3), available prophylactic agents14 and national treatment 
policies.15 National and provincial health departments should 
consider a change in treatment policy from quinine to ACT for 
the treatment of patients with uncomplicated malaria at public 
sector facilities in non-malaria-risk provinces.
We thank the clinicians and nursing personnel who participated in 
this study by submitting questionnaires, the Gauteng Department 
of Health, the South African National Health Laboratory Service, 
and Lancet and Ampath laboratories for providing us with 
supplementary data to corroborate patient laboratory results.
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Figure 3.  Malaria risk in Southern Africa—January 2007 
 
 Fig. 3.  Malaria risk in southern Africa, January 2007.14
